Flemming Ornskov - Shire
Last quote by Flemming Ornskov
Our priorities for the rest of 2017 remain unchanged: launching new products while driving commercial excellence, generating operational efficiencies, and advancing our pipeline of novel therapies. Additionally, we continue to prioritise paying down debt, and we are on track to achieve our full-year financial guidance. Looking ahead, I see tremendous opportunity for further growth as we continue to build on our position as the global leader in treating patients with rare diseases.feedback
May 02 2017
We can learn a lot about a person if we know what types of things he or she talks about or comments on the most frequently. There are numerous topics with which Flemming Ornskov is associated, including Shire and Xiidra. Most recently, Flemming Ornskov has been quoted saying: “We can expect for all our categories, not just hemophilia, tighter management, but we have the programs in place to make sure this does not affect our patients and has limited impact on our overall business.” in the article Shire slips on poor sales of hemophilia drugs.
Take our quote verification challenge and find out !
Quotes by Flemming Ornskov
Nov 01 2016
We can expect for all our categories, not just hemophilia, tighter management, but we have the programs in place to make sure this does not affect our patients and has limited impact on our overall business.feedback
Jul 12 2016
As Shire's first FDA-approved medicine in ophthalmics, this significant milestone advances our goal of becoming the global leader in this category, where there are unmet patient needs. We have a robust ophthalmics pipeline, and we look forward to leveraging Xiidra as our entrée into the space as we continue to develop additional innovative eye care treatment options.feedback
Apr 29 2016
Shire is off to a strong start in 2016.feedback
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided